Literature DB >> 33708117

Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension.

Laale F Alawi1, Sanjeev Dhakal1, Sana E Emberesh1, Harshal Sawant1, Anhar Hosawi1, Unmesha Thanekar1, Nadja Grobe1, Khalid M Elased1.   

Abstract

Activation of the renin angiotensin system plays a pivotal role in the regulation of blood pressure, which is mainly attributed to the formation of angiotensin-II (Ang II). The actions of Ang II are mediated through binding to the Ang-II type 1 receptor (AT1R) which leads to increased blood pressure, fluid retention, and aldosterone secretion. In addition, Ang II is also involved in cell injury, vascular remodeling, and inflammation. The actions of Ang II could be antagonized by its conversion to the vasodilator peptide Ang (1-7), partly generated by the action of angiotensin converting enzyme 2 (ACE2) and/or neprilysin (NEP). Previous studies demonstrated increased urinary ACE2 shedding in the db/db mouse model of diabetic kidney disease. The aim of the study was to investigate whether renal and urinary ACE2 and NEP are altered in the 2K1C Goldblatt hypertensive mice. Since AT1R is highly expressed in the kidney, we also researched the effect of global deletion of AT1R on renal and urinary ACE2, NEP, and kidney injury marker (KIM-1). Hypertension and albuminuria were induced in AT1R knock out (AT1RKO) and WT mice by unilateral constriction of the renal artery of one kidney. The 24 h mean arterial blood pressure (MAP) was measured using radio-telemetry. Two weeks after 2K1C surgery, MAP and albuminuria were significantly increased in WT mice compared to AT1RKO mice. Results demonstrated a correlation between MAP and albuminuria. Unlike db/db diabetic mice, ACE2 and NEP expression and activities were significantly decreased in the clipped kidney of WT and AT1RKO compared with the contralateral kidney and sham control (p < 0.05). There was no detectable urinary ACE2 and NEP expression and activity in 2K1C mice. KIM-1 was significantly increased in the clipped kidney of WT and AT1KO (p < 0.05). Deletion of AT1R has no effect on the increased urinary KIM-1 excretion detected in 2K1C mice. In conclusion, renal injury in 2K1C Goldblatt mouse model is associated with loss of renal ACE2 and NEP expression and activity. Urinary KIM-1 could serve as an early indicator of acute kidney injury. Deletion of AT1R attenuates albuminuria and hypertension without affecting renal ACE2, NEP, and KIM-1 expression.
Copyright © 2021 Alawi, Dhakal, Emberesh, Sawant, Hosawi, Thanekar, Grobe and Elased.

Entities:  

Keywords:  2K1C Goldblatts’ model; ACE2 (angiotensin converting Enzyme-2); angiotensin II (A II) receptor antagonists; chronic kidney; hypertension; neprilysin (NEP); renin angiotensin aldestron system; urinary bio markers

Year:  2021        PMID: 33708117      PMCID: PMC7941277          DOI: 10.3389/fphar.2020.602985

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  62 in total

1.  Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.

Authors:  Adriaan A Voors; Mauro Gori; Licette C Y Liu; Brian Claggett; Michael R Zile; Burkert Pieske; John J V McMurray; Milton Packer; Victor Shi; Martin P Lefkowitz; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2015-02-06       Impact factor: 15.534

2.  Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.

Authors:  Masato Furuhashi; Norihito Moniwa; Tomohiro Mita; Takahiro Fuseya; Shutaro Ishimura; Kohei Ohno; Satoru Shibata; Marenao Tanaka; Yuki Watanabe; Hiroshi Akasaka; Hirofumi Ohnishi; Hideaki Yoshida; Hideki Takizawa; Shigeyuki Saitoh; Nobuyuki Ura; Kazuaki Shimamoto; Tetsuji Miura
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

Review 3.  Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.

Authors:  So-Young Lee; Mary E Choi
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

4.  Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.

Authors:  Sridevi Gutta; Nadja Grobe; Meenasri Kumbaji; Hassan Osman; Mohammad Saklayen; Gengxin Li; Khalid M Elased
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-21

5.  Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Fady T Botros; Javier Pagan; Hiroyuki Kobori; Dale M Seth; Dulce E Casarini; L Gabriel Navar
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

6.  Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients.

Authors:  Ciorba Pop Mariana; Potra Alina Ramona; Bondor Cosmina Ioana; Moldovan Diana; Rusu Crina Claudia; Vladutiu Dan Stefan; Kacso Ina Maria
Journal:  Int Urol Nephrol       Date:  2016-06-16       Impact factor: 2.370

7.  Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury.

Authors:  Fei Fang; George Chu Liu; Xiaohua Zhou; Stuart Yang; Heather Naomi Reich; Vanessa Williams; Amanda Hu; Janice Pan; Ana Konvalinka; Gavin Yadram Oudit; James William Scholey; Rohan John
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

9.  Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice.

Authors:  Laale F Alawi; Sana E Emberesh; Brenda A Owuor; Harshita Chodavarapu; Rucha Fadnavis; Salim S El-Amouri; Khalid M Elased
Journal:  Physiol Rep       Date:  2020-02

10.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

View more
  3 in total

Review 1.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

2.  Analysis of mRNA and protein kidney injury Molecule-1 (KIM-1) expression in a kidney model during the initiation phase of ischemia reperfusion injury.

Authors:  Jerny Dase; Haerani Rasyid; Rina Masadah; Muhammad Husni Cangara; Agussalim Bukhari; Ressy Dwiyanti; Mochammad Hatta
Journal:  Ann Med Surg (Lond)       Date:  2022-02-11

3.  A New Approach for the Development of Multiple Cardiovascular Risk Factors in Two Rat Models of Hypertension.

Authors:  Karyne Garcia Tafarelo Moreno; Aline Aparecida Macedo Marques; Gabriela Pereira da Silva; Bethânia Rosa Lourençone; Clara Soligo Fortini; Patrícia Regina Terço Leite; Ariany Carvalho Dos Santos; Roosevelt Isaías Carvalho Souza; Leila Isabel da Siva; Arquimedes Gasparotto Junior
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.